Celsense

 

 

NEWS RELEASE - For Immediate Release

Celsense, Inc. Announces SBIR Award

February 15, 2008 - Pittsburgh, Pennsylvania

Celsense, Inc. announced that it has been awarded a Small Business Innovative Research grant of $273,000 by the U.S. National Institutes of Health. Proceeds from the award will be used to demonstrate the in vitro safety of Cell Sense using human cells. Robbie Mailliard, Director of R&D at Celsense, is the Principal Investigator in the grant application.

“To date, our experimental work has centered on mammalian cells in the preclinical setting. Using human cells, we hope to demonstrate the safety of Cell Sense in multiple cell types. This research is an important step toward broad use of Cell Sense in human health,” said Dr. Mailliard.

About Celsense, Inc. Celsense is a Pittsburgh based biotechnology company offering products that enable the real-time in vivo imaging of transplanted cells for therapeutic and diagnostic purposes. The mission of the company is to be the imaging standard for transplanted cells in human health.

Contact Information:

Charlie O’Hanlon, President and CEO
Celsense, Inc.
(412) 263-2870
charlie@celsense.com